Holen Sie sich die Stockscreener-App
18.02
6.31%
1.07
Handel nachbörslich:
18.02
Schlusskurs vom Vortag:
$16.95
Offen:
$17.11
24-Stunden-Volumen:
542.98K
Relative Volume:
1.55
Marktkapitalisierung:
$616.51M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-81.05M
KGV:
-6.8695
EPS:
-2.6232
Netto-Cashflow:
$-68.97M
1W Leistung:
-5.61%
1M Leistung:
-16.69%
6M Leistung:
-32.89%
1J Leistung:
-22.03%
1-Tages-Spanne:
$16.64
$18.42
1-Wochen-Bereich:
$16.10
$19.20
52-Wochen-Spanne:
$15.47
$36.37
Arrivent Biopharma Inc Stock (AVBP) Company Profile
Firmenname
Arrivent Biopharma Inc
Sektor
Branche
Telefon
240-780-6356
Adresse
18 CAMPUS BLVD., NEWTOWN SQUARE
Vergleichen Sie AVBP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVBP
Arrivent Biopharma Inc
|
18.02 | 687.64M | 0 | -81.05M | -68.97M | -2.6232 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Arrivent Biopharma Inc Stock (AVBP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Fortgesetzt | Goldman | Buy |
| 2025-03-20 | Eingeleitet | B. Riley Securities | Buy |
| 2025-03-10 | Eingeleitet | Guggenheim | Buy |
| 2024-07-22 | Eingeleitet | Oppenheimer | Outperform |
| 2024-04-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-02-20 | Eingeleitet | Citigroup | Buy |
| 2024-02-20 | Eingeleitet | Goldman | Buy |
| 2024-02-20 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Arrivent Biopharma Inc Aktie (AVBP) Neueste Nachrichten
News impact scoring models applied to ArriVent BioPharma Inc.July 2025 EndofMonth & Real-Time Stock Movement Alerts - Newser
ArriVent BioPharma Inc. stock retracement – recovery analysisM&A Rumor & Real-Time Volume Trigger Notifications - Newser
ArriVent Biopharma price target raised to $42 from $40 at H.C. Wainwright - TipRanks
A Quick Look at Today's Ratings for ArriVent BioPharma(AVBP.US), With a Forecast Between $33 to $45 - 富途牛牛
ArriVent Biopharma price target lowered to $33 from $40 at Citi - TipRanks
H.C. Wainwright raises ArriVent BioPharma stock price target to $42 on NSCLC drug potential - Investing.com Canada
Candlestick signals on ArriVent BioPharma Inc. stock todayFree Weekly Watchlist of High Movers - Newser
ArriVent BioPharma Inc. stock trend outlook and recovery pathFree Short Term High Yield Stock Tips - Newser
How to interpret RSI for ArriVent BioPharma Inc. stockPattern Breakout Prediction for Short Term - Newser
What makes ArriVent BioPharma Inc. stock price move sharplyFree Real Time Alerts Based on AI Prediction - Newser
ArriVent Biopharma sees cash runway into mid-2027 - TipRanks
Does ArriVent BioPharma Inc. fit your quant trading modelFree Earnings Play Trade Plan With Alerts - Newser
Why ArriVent BioPharma Inc. stock attracts strong analyst attentionFree Low Capital High Return Stock Plans - Newser
ArriVent Biopharma reports Q2 EPS (90c), consensus (71c) - TipRanks
Does ArriVent BioPharma Inc. qualify in momentum factor screeningSector Rotation Strategy for Smart Traders - Newser
Understanding ArriVent BioPharma Inc.’s price movementFree Breakout Entry Signal Confirmation Tool - Newser
ArriVent Posts Wider Loss in Fiscal Q2 - The Motley Fool
ArriVent Posts Wider Loss in Fiscal Q2 - The Globe and Mail
ArriVent BioPharma, Inc. SEC 10-Q Report - TradingView
ArriVent BioPharma Reports Second Quarter 2025 Financial Results - Stock Titan
Custom strategy builders for tracking ArriVent BioPharma Inc.Free Triple Return Setup with Risk Control - Newser
ArriVent BioPharma (AVBP) Projected to Post Quarterly Earnings on Wednesday - Defense World
Predicting ArriVent BioPharma Inc. trend using moving averagesFree Consistent Profit Pattern Recognition Tools - Newser
ArriVent BioPharma Inc. recovery potential after sell offExit Strategy Guide With Risk Control Plan - Newser
How hedge fund analytics apply to ArriVent BioPharma Inc. stockEntry Confirmation Using Short-Term Forecasting - Newser
Will ArriVent BioPharma Inc. price bounce be sustainableEntry Timing Tracker with Alert Accuracy - Newser
Lepu Biopharma Reports First-Ever Profit Amid Revenue Surge - TipRanks
ArriVent BioPharma Inc. Company’s Quarterly Earnings Growth: What the Numbers SayWeekly Return Plan for Conservative Traders - Newser
Thermo Fisher to lay off 85 workers in San Diego County; Lepu Biopharma inks a deal - Endpoints News
How many analysts rate ArriVent BioPharma Inc. as a “Buy”Capitalize on high-growth stocks early - Jammu Links News
What is ArriVent BioPharma Inc. company’s growth strategyGet exclusive market insights for better trading - Jammu Links News
ArriVent BioPharma Inc. Stock Analysis and ForecastTrack high-yield stocks before they peak - Jammu Links News
How strong is ArriVent BioPharma Inc. company’s balance sheetMaximize gains with proven stock analysis - Jammu Links News
What is the risk reward ratio of investing in ArriVent BioPharma Inc. stockTake advantage of unprecedented market momentum - Jammu Links News
Why is ArriVent BioPharma Inc. stock attracting strong analyst attentionStay ahead with advanced stock screening tools - Jammu Links News
How volatile is ArriVent BioPharma Inc. stock compared to the marketDynamic growth stocks - Jammu Links News
Is ArriVent BioPharma Inc. stock overvalued or undervaluedCapitalize on fast-growing stocks today - Jammu Links News
What are ArriVent BioPharma Inc. company’s key revenue driversUnlock powerful market insights for success - Jammu Links News
How does ArriVent BioPharma Inc. compare to its industry peersUnlock exclusive stock market forecasts - Jammu Links News
Does ArriVent BioPharma Inc. stock perform well during market downturnsSuperior trading gains - Jammu Links News
When is ArriVent BioPharma Inc. stock expected to show significant growthBuild a winning portfolio with smart picks - Jammu Links News
How does ArriVent BioPharma Inc. generate profit in a changing economyFree Stock Market Knowledge Sharing - Jammu Links News
ArriVent BioPharma Inc. stock prediction for this weekAI Generated Buy/Sell Signal Forecast - Newser
Can you recover from losses in ArriVent BioPharma Inc.Free Real Trader Watchlist of Hot Stocks - Newser
Can trapped investors hope for a rebound in ArriVent BioPharma Inc.Predictive Short-Term Market Reversal Alerts - Newser
Using data models to predict ArriVent BioPharma Inc. stock movementFree Fundamental + Technical Hybrid Stock Tips - Newser
Quant Tools Rank ArriVent BioPharma Inc. as High Risk High RewardTrend Analysis for Safer Trades Gains Popularity - metal.it
Finanzdaten der Arrivent Biopharma Inc-Aktie (AVBP)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):